Low Levels of Asymmetric Dimethylarginine in Children with Diabetes Mellitus Type I Compared with Healthy Children
Martina Huemer(University Children's Hospital Zurich), Olaf A. Bodamer(Broad Institute), Edith Schober(Medical University of Vienna), Birgit Rami‐Merhar, D Mayr(Landeskrankenhaus Feldkirch), Ulrike Zanier(Krankenhaus Oberndorf), Adolf Mühl(Medical University of Vienna), Burkhard Simma(Landeskrankenhaus Feldkirch), Hanno Ulmer(Innsbruck Medical University)
Cited by 20
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|823
Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia
|Orphanet Journal of Rare Diseases|2014|713
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
|European Journal of Pediatrics|2007|535
Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989–2013: a multicentre prospective registration study
|Diabetologia|2018|516
Guidelines for the diagnosis and management of cystathionine beta‐synthase deficiency
|Journal of Inherited Metabolic Disease|2016|335